Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many of the advance purchases of covid-19 vaccines have been bought from manufacturers based in the UK.

The UK Government has secured access to two vaccines being manufactured in the UK:

• 100 million doses of the vaccine being developed by the University of Oxford and AstraZeneca.
• 60 million doses of the vaccine being developed by GlaxoSmithKline and Sanofi Pasteur.

The UK Government has also secured access to the vaccine being developed by Valneva, who are based in France but will manufacture the vaccine in Scotland.